PAOLINI PAOLETTI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 921
AS - Asia 757
EU - Europa 483
SA - Sud America 93
AF - Africa 17
OC - Oceania 3
Totale 2.274
Nazione #
US - Stati Uniti d'America 903
SG - Singapore 362
CN - Cina 126
HK - Hong Kong 122
IE - Irlanda 105
IT - Italia 101
BR - Brasile 83
DE - Germania 66
RU - Federazione Russa 53
VN - Vietnam 44
FI - Finlandia 40
KR - Corea 40
GB - Regno Unito 22
IN - India 21
RO - Romania 20
FR - Francia 14
CA - Canada 13
SE - Svezia 10
AT - Austria 9
NL - Olanda 9
JP - Giappone 8
AR - Argentina 6
ES - Italia 6
PL - Polonia 6
IQ - Iraq 5
ZA - Sudafrica 5
ID - Indonesia 4
UA - Ucraina 4
UZ - Uzbekistan 4
BD - Bangladesh 3
BE - Belgio 3
CH - Svizzera 3
LT - Lituania 3
MD - Moldavia 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DK - Danimarca 2
IS - Islanda 2
KG - Kirghizistan 2
MA - Marocco 2
MX - Messico 2
TR - Turchia 2
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
CM - Camerun 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
PA - Panama 1
PG - Papua Nuova Guinea 1
PK - Pakistan 1
PY - Paraguay 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
VE - Venezuela 1
ZM - Zambia 1
Totale 2.274
Città #
Singapore 246
Chandler 167
Hong Kong 121
Dublin 105
Ashburn 64
Boardman 59
Seoul 40
Santa Clara 39
Perugia 36
San Mateo 35
Munich 34
Los Angeles 31
Beijing 22
Helsinki 21
Timisoara 19
Lawrence 18
Medford 18
Princeton 18
Turku 17
Wilmington 17
New York 16
Piscataway 16
Moscow 15
Altamura 14
São Paulo 14
Falls Church 13
Andover 12
Chennai 12
Des Moines 12
Ho Chi Minh City 12
Hanoi 11
Brooklyn 10
Nuremberg 10
Redwood City 10
Dallas 8
Houston 8
Stockholm 8
Tokyo 8
London 7
Montreal 7
Rome 7
The Dalles 7
Boston 6
Poplar 6
West Jordan 6
Denver 5
Dong Ket 5
Fairfield 5
Hefei 5
Orem 5
Redmond 5
Atlanta 4
Chicago 4
Columbus 4
Milan 4
Saint Petersburg 4
Tashkent 4
Verona 4
Warsaw 4
Amsterdam 3
Belo Horizonte 3
Cosenza 3
Curitiba 3
Da Nang 3
El Paso 3
Frankfurt am Main 3
Johannesburg 3
Mumbai 3
Phoenix 3
San Paolo di Civitate 3
Vienna 3
Baghdad 2
Brixen 2
Brussels 2
Campinas 2
Carney 2
Casablanca 2
Chisinau 2
Dubai 2
Erbil 2
Falkenstein 2
Florence 2
Genoa 2
Grand Rapids 2
Guangzhou 2
Huzhou 2
Itabira 2
Lappeenranta 2
Manchester 2
Miami 2
Minneapolis 2
Ninh Bình 2
Ottawa 2
Pittsburgh 2
Porto Alegre 2
Raleigh 2
Reykjavik 2
Rio de Janeiro 2
Secaucus 2
Shanghai 2
Totale 1.538
Nome #
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 102
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 98
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 90
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 89
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 86
Levodopa-responsive breathing discomfort in Parkinson’s disease patients 85
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 82
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 78
Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers 77
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease 74
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 73
Levodopa treatment in Parkinson's disease: earlier or later? 71
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 70
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 70
Drug-induced Creutzfeldt-Jakob disease-like syndrome: Early CSF analysis as useful tool for differential diagnosis 67
Molecular profiling in Parkinsonian syndromes: CSF biomarkers 65
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers. 63
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 63
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 61
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease 59
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 58
Blood biomarkers may distinguish among dementia disorders 57
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 53
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 52
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 51
Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study 51
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 50
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 49
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 49
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 46
Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with MCI 43
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 42
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 41
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 41
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 40
Incidence and Risk Factors Epilepsy in Patients with Dementia: A Population-Based Study Using Regional Healthcare Databases in Umbria 32
Research advancement in fluid biomarkers for Parkinson's disease 29
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approach 23
Totale 2.330
Categoria #
all - tutte 12.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 8 4 3 2 8 2 6
2021/2022134 0 23 0 0 5 8 4 34 10 11 20 19
2022/2023467 19 104 7 35 41 51 1 27 154 5 14 9
2023/2024253 16 25 8 4 4 2 42 6 46 12 45 43
2024/2025625 11 51 38 36 60 44 21 43 118 48 101 54
2025/2026739 98 104 60 191 212 74 0 0 0 0 0 0
Totale 2.330